30 results
8-K
EX-99.1
BTAX
Biostax Corp.
14 Nov 23
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
4:22pm
Secretary of Health and Human Resources under the office of Secretary Jane Woods where he exhibited exceptional leadership in policy coordination … empowerment, Craig Suro continues to shape Virginia’s future. His dynamic approach and visionary leadership make him a driving force behind transformative
8-K
EX-99.1
BTAX
Biostax Corp.
14 Sep 23
Biostax Corp Announces the Passing of Esteemed Director, Henry Louis Salomonsky
9:00am
a wealth of knowledge, experience, and leadership.
Biostax expresses its deepest condolences to Mr. Salomonksy’s family during this difficult time. His
PRE 14C
BTAX
Biostax Corp.
16 Dec 22
Preliminary information
4:31pm
leadership and his previous board memberships.
Glen Farmer. Mr. Farmer was appointed as the Chief Executive Officer on August 2022. From April 2018
8-K
BTAX
Biostax Corp.
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
of operational leadership and his previous board memberships. Mr. Salomonsky was appointed to serve on the Board until his successor is duly elected
8-K
EX-99.1
h6j2wn9fl0tbzrlkr0t7
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
8-K
EX-99.1
z7s77 jv15isl
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
f4tet19hn90f7i w2cxr
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
dhk5h3
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
dh3hcyrubcby2av5
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
8-K
wmi41xky q21ytv0m5g9
5 May 20
Departure of Directors or Certain Officers
5:19pm
8-K
svq58xh 33492hqt
14 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
j9qg00
14 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
jyj8c1lq1 bz2rd0x
4 Dec 14
Other Events
12:00am
10-K
o95iaxrql942 hqo
31 Mar 14
Annual report
12:00am
10-12G/A
nb1w vjzr
7 Feb 14
Registration of securities (amended)
12:00am